MDXH
MDxHealth
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
MDXH Profile
Mdxhealth Sa
A commercial-stage precision diagnostics company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer
CAP Business Center, Zone Industrielle des Hauts-Sarts, 4040 Herstal, Belgium
--
MDxHealth SA, a leader in molecular diagnostics, is a company that develops and commercializes advanced epigenetic analysis and service testing for cancer assessment and personalized treatment of patients. MDxHealth SA was established on January 10, 2003. The campaign is organized around two product families: (1) Epigenetic Molecular Testing (ConfirmMDx): a useful and innovative test that enables researchers to correctly identify and treat prostate cancer; and (2) Non-invasive liquid biopsy testing (SelectMDx): a test to assess the risk of aggressive prostate cancer during biopsy.